Suppr超能文献

瑞典儿科心脏移植的头二十年——列表结果和移植后结果。

First two decades of paediatric heart transplantation in Sweden - outcome of listing and post-transplant results.

机构信息

Pediatric Cardiology, Queen Silvia Children's Hospital, Sahlgrenska Academy, Gothenburg University, Sweden.

出版信息

Acta Paediatr. 2011 Nov;100(11):1442-7. doi: 10.1111/j.1651-2227.2011.02377.x. Epub 2011 Jun 23.

Abstract

AIMS

To evaluate outcome in the first generation of children with end-stage heart disease to whom heart transplantation was available.

METHODS

Retrospective review of all 135 Swedish children <18 years old listed for heart transplantation 1989-2009, followed to December 31, 2009, including 74 (55%) with cardiomyopathy and 61 (45%) with congenital heart disease; 34 (25%) were infants (<1 year). Cumulative risk of requiring heart transplantation was 1:17,300 (11 patients who improved were omitted from outcome analysis).

RESULTS

Waiting-list mortality was 31% (44% in infants). Median waiting time in 82 transplanted patients was 57 days (0-585 days). Post-transplant follow-up time was median 5.9 years (0.03-20.1 years), and actuarial survival was 92% at 1 year, 82% at 5 years, 76% at 10 years and 58% at 15 years. Survival after listing was 64% at 1 year, 58% at 5 years, 52% at 10 years and 40% at 15 years. Post-transplant complications included rejections (34%), malignancies (12%), renal failure (8%), coronary artery vasculopathy (6%) and re-transplantation (5%). Among 64 survivors, 84% were free of complications affecting prognosis.

CONCLUSION

High waiting-list mortality and post-transplant attrition precluded 60% of this pioneer population from reaching adulthood. Functional status in survivors is generally good.

摘要

目的

评估可进行心脏移植的第一代终末期心脏病儿童的治疗结果。

方法

回顾性分析了 1989 年至 2009 年瑞典所有 135 名 <18 岁的接受心脏移植的儿童患者,其中包括 74 例(55%)扩张型心肌病和 61 例(45%)先天性心脏病;34 例(25%)为婴儿(<1 岁)。需要心脏移植的累积风险为 1:17300(11 例改善的患者被排除在结果分析之外)。

结果

等待名单上的死亡率为 31%(婴儿为 44%)。82 例移植患者的中位等待时间为 57 天(0-585 天)。移植后中位随访时间为 5.9 年(0.03-20.1 年),1 年生存率为 92%,5 年生存率为 82%,10 年生存率为 76%,15 年生存率为 58%。列表后生存率为 1 年 64%,5 年 58%,10 年 52%,15 年 40%。移植后并发症包括排斥反应(34%)、恶性肿瘤(12%)、肾衰竭(8%)、冠状动脉血管病(6%)和再次移植(5%)。在 64 例幸存者中,84%无影响预后的并发症。

结论

高的等待名单死亡率和移植后失访率使该先驱人群的 60%无法达到成年。幸存者的功能状态通常良好。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验